Anagenics Limited reported earnings results for the half year ended December 31, 2021. For the half year, the company reported sales was AUD 4.18 million compared to AUD 2.79 million a year ago. Net loss was AUD 1.75 million compared to AUD 2.39 million a year ago.

Basic loss per share from continuing operations was AUD 0.0089 compared to AUD 0.0182 a year ago. Diluted loss per share from continuing operations was AUD 0.0089 compared to AUD 0.0182 a year ago. Basic loss per share was AUD 0.0089 compared to AUD 0.0191 a year ago.

Diluted loss per share was AUD 0.0089 compared to AUD 0.0191 a year ago.